YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
GAITHERSBURG, Md., Feb. 16, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results of its extraordinary general meeting (the “EGM”) held on February … Read more